ID	Database	Citation
3798106	Pubmed	"Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science. 1987 Jan 9;235(4785):177–82.  <a href=""http://www.ncbi.nlm.nih.gov/pubmed/3798106"" target=""_blank"" class=""external"" rel=""nofollow"">PubMed</a> <a href=""https://europepmc.org/abstract/MED/3798106"" target=""_blank"" class=""external"" rel=""nofollow"">Europe PMC</a> <a href=""https://scholia.toolforge.org/pubmed/3798106"" target=""_blank"" class=""external"" rel=""nofollow"">Scholia</a>"
15805248	Pubmed	"Saal LH, Holm K, Maurer M, Memeo L, Su T, Wang X, et al. PIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinoma. Cancer Res. 2005 Apr 1;65(7):2554–9.  <a href=""http://www.ncbi.nlm.nih.gov/pubmed/15805248"" target=""_blank"" class=""external"" rel=""nofollow"">PubMed</a> <a href=""https://europepmc.org/abstract/MED/15805248"" target=""_blank"" class=""external"" rel=""nofollow"">Europe PMC</a> <a href=""https://scholia.toolforge.org/pubmed/15805248"" target=""_blank"" class=""external"" rel=""nofollow"">Scholia</a>"
17397528	Pubmed	"Elbauomy Elsheikh S, Green AR, Lambros MBK, Turner NC, Grainge MJ, Powe D, et al. FGFR1 amplification in breast carcinomas: a chromogenic in situ hybridisation analysis. Breast Cancer Res. 2007;9(2):R23.  <a href=""http://www.ncbi.nlm.nih.gov/pubmed/17397528"" target=""_blank"" class=""external"" rel=""nofollow"">PubMed</a> <a href=""https://europepmc.org/abstract/MED/17397528"" target=""_blank"" class=""external"" rel=""nofollow"">Europe PMC</a> <a href=""https://scholia.toolforge.org/pubmed/17397528"" target=""_blank"" class=""external"" rel=""nofollow"">Scholia</a>"
18676830	Pubmed	"Stemke-Hale K, Gonzalez-Angulo AM, Lluch A, Neve RM, Kuo W-L, Davies M, et al. An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer. Cancer Res. 2008 Aug 1;68(15):6084–91.  <a href=""http://www.ncbi.nlm.nih.gov/pubmed/18676830"" target=""_blank"" class=""external"" rel=""nofollow"">PubMed</a> <a href=""https://europepmc.org/abstract/MED/18676830"" target=""_blank"" class=""external"" rel=""nofollow"">Europe PMC</a> <a href=""https://scholia.toolforge.org/pubmed/18676830"" target=""_blank"" class=""external"" rel=""nofollow"">Scholia</a>"
20453058	Pubmed	"O’Brien C, Wallin JJ, Sampath D, GuhaThakurta D, Savage H, Punnoose EA, et al. Predictive biomarkers of sensitivity to the phosphatidylinositol 3’ kinase inhibitor GDC-0941 in breast cancer preclinical models. Clin Cancer Res. 2010 Jul 15;16(14):3670–83.  <a href=""http://www.ncbi.nlm.nih.gov/pubmed/20453058"" target=""_blank"" class=""external"" rel=""nofollow"">PubMed</a> <a href=""https://europepmc.org/abstract/MED/20453058"" target=""_blank"" class=""external"" rel=""nofollow"">Europe PMC</a> <a href=""https://scholia.toolforge.org/pubmed/20453058"" target=""_blank"" class=""external"" rel=""nofollow"">Scholia</a>"
20570901	Pubmed	"Hynes NE, Dey JH. Potential for targeting the fibroblast growth factor receptors in breast cancer. Cancer Res. 2010 Jul 1;70(13):5199–202.  <a href=""http://www.ncbi.nlm.nih.gov/pubmed/20570901"" target=""_blank"" class=""external"" rel=""nofollow"">PubMed</a> <a href=""https://europepmc.org/abstract/MED/20570901"" target=""_blank"" class=""external"" rel=""nofollow"">Europe PMC</a> <a href=""https://scholia.toolforge.org/pubmed/20570901"" target=""_blank"" class=""external"" rel=""nofollow"">Scholia</a>"
23220880	Pubmed	"Bose R, Kavuri SM, Searleman AC, Shen W, Shen D, Koboldt DC, et al. Activating HER2 mutations in HER2 gene amplification negative breast cancer. Cancer Discov. 2013 Feb;3(2):224–37.  <a href=""http://www.ncbi.nlm.nih.gov/pubmed/23220880"" target=""_blank"" class=""external"" rel=""nofollow"">PubMed</a> <a href=""https://europepmc.org/abstract/MED/23220880"" target=""_blank"" class=""external"" rel=""nofollow"">Europe PMC</a> <a href=""https://scholia.toolforge.org/pubmed/23220880"" target=""_blank"" class=""external"" rel=""nofollow"">Scholia</a>"
26028978	Pubmed	"Mukohara T. PI3K mutations in breast cancer: prognostic and therapeutic implications. Breast Cancer (Dove Med Press). 2015 May 15;7:111–23.  <a href=""http://www.ncbi.nlm.nih.gov/pubmed/26028978"" target=""_blank"" class=""external"" rel=""nofollow"">PubMed</a> <a href=""https://europepmc.org/abstract/MED/26028978"" target=""_blank"" class=""external"" rel=""nofollow"">Europe PMC</a> <a href=""https://scholia.toolforge.org/pubmed/26028978"" target=""_blank"" class=""external"" rel=""nofollow"">Scholia</a>"
27251275	Pubmed	"Mertins P, Mani DR, Ruggles KV, Gillette MA, Clauser KR, Wang P, et al. Proteogenomics connects somatic mutations to signalling in breast cancer. Nature. 2016 Jun 2;534(7605):55–62.  <a href=""http://www.ncbi.nlm.nih.gov/pubmed/27251275"" target=""_blank"" class=""external"" rel=""nofollow"">PubMed</a> <a href=""https://europepmc.org/abstract/MED/27251275"" target=""_blank"" class=""external"" rel=""nofollow"">Europe PMC</a> <a href=""https://scholia.toolforge.org/pubmed/27251275"" target=""_blank"" class=""external"" rel=""nofollow"">Scholia</a>"
28348404	Pubmed	"Huang K-L, Li S, Mertins P, Cao S, Gunawardena HP, Ruggles KV, et al. Proteogenomic integration reveals therapeutic targets in breast cancer xenografts. Nat Commun. 2017 Mar 28;8:14864.  <a href=""http://www.ncbi.nlm.nih.gov/pubmed/28348404"" target=""_blank"" class=""external"" rel=""nofollow"">PubMed</a> <a href=""https://europepmc.org/abstract/MED/28348404"" target=""_blank"" class=""external"" rel=""nofollow"">Europe PMC</a> <a href=""https://scholia.toolforge.org/pubmed/28348404"" target=""_blank"" class=""external"" rel=""nofollow"">Scholia</a>"
